红日药业：公司完全正视并深刻认知当前股价表现对公司市场形象、再融资能力及投资者回报等带来的严峻挑战

Group 1 - The company acknowledges the severe challenges posed by its current stock price performance on market image, refinancing ability, and investor returns [1] - The pharmaceutical industry evaluates companies based on scale, financial stability, product efficacy, supply capability, and technological barriers [1] - The company aims to enhance intrinsic value and achieve sustainable development as the foundation of market value management [1] Group 2 - The company will focus on core business operations to improve profitability [1] - The company plans to strengthen corporate governance and transparency [1] - The company will enhance communication with investors to promote market recognition of its value [1]